Can we prevent cancer?

    -   Gairdner Foundation presents a free public forum on Advances and
        Opportunities in Cancer Prevention on Wednesday, Oct. 24th at the
        University of Toronto.
    -   World's top cancer researchers discuss our increasing understanding
        of how cancer can be prevented.

    TORONTO, Oct. 5 /CNW/ - The Gairdner Foundation ( is
bringing eight of the world's most respected scientists in cancer prevention
to Toronto to discuss their work, including the opportunities and the
limitations for preventing cancer. The Gairdner Foundation is partnering in
this initiative with Cancer Care Ontario, the Ontario Division of the Canadian
Cancer Society and the National Cancer Institute of Canada.
    All of these scientists will speak at a day-long Cancer Prevention Forum
that is free and open to the public on Wednesday, October 24th, from 8:30 a.m.
to 4:15 p.m. in the Main Auditorium, Department of Public Health Sciences,
University of Toronto, 155 College Street.
    Said Gairdner President, Dr. John Dirks: "Part of our mandate is to
demonstrate the importance of medical research in all our lives and I can't
think of a subject more relevant and compelling than how research can prevent
    Among the speakers are Sir Richard Peto from Oxford University, who first
proved the link between smoking and cancer and who will discuss "Cancer
mortality trends attributed to and not attributed to tobacco," and Dr. Douglas
Lowy from the National Institutes of Health in Bethesda, whose work led to the
creation of the HPV vaccine to prevent cervical cancer.
    A full list of speakers and subjects is attached.
    The Cancer Forum takes place the day before the Gairdner Gala Banquet, on
October 25th, when the 2007 Gairdner Awards ("The Gairdners") will be
presented to five international scientists for their fundamental discoveries
that will have an impact on genetic development, cancer and many other
    The Cancer Forum is made possible through a contribution to the Gairdner
Foundation by Merck Frosst Canada Ltd.
    The Gairdners ( are Canada's top biomedical prize. Now
in their 48th year, they have grown to be one of the most prestigious awards
in all of science, recognizing outstanding contributions by medical scientists
world wide, whose work will significantly improve the quality of life. Of the
283 Gairdner awardees, 68 have gone on to win the Nobel Prize.
    Since 2003, the Canadian Institutes for Health Research (CIHR) has been
the national sponsor of the Gairdner Awards. CIHR is the major federal agency
responsible for funding health research in Canada, supporting the work of
10,000 researchers in universities, teaching hospitals and research institutes
across Canada. The results are improved health for Canadians, more effective
health services and products and a strengthened Canadian health care system.

                 The Gairdner Foundation in partnership with
                CCS (Ontario Division) - NCIC and CCO present

               Advances and Opportunities in Cancer Prevention:
                          A Cancer Prevention Forum

                   Wednesday, October 24, 8:30am - 4:15pm

            Main Auditorium, Department of Public Health Sciences
      University of Toronto, 155 College Street, Room HS610 (6th floor)
                              Admission is free

    8:30     Opening remarks - John Dirks (Gairdner Foundation),
             Terry Sullivan (CCO),
             Peter Goodhand (CCS)

    Risk Factors and their Modifiability

    8:45     Dr. Richard Peto, Oxford University, Oxford
             Treatment of early breast cancer and halving premature death
    9:30     Dr. Salim Yusef, McMaster University, Hamilton
             Can we prevent the majority of CVD in the foreseeable future by
             targeting risk factors?
    10:15    Break

    Cancer Genetics and Prevention in High Risk Populations

    10:30    Dr. Bruce Ponder, Cambridge Research Institute, Cambridge
             Breast cancer susceptibility and control
    11:15    Dr. Steve Gallinger, Samuel Lunenfeld Research Inst. & Mount
             Sinai Hospital, Toronto
             Genome-wide association studies in colorectal cancer

    Infection and Vaccination in Cancer Prevention

    12:45    Dr. Lorne Tyrrell, University of Alberta, Edmonton
             Hepatitis B vaccine and prevention of liver cancer
    1:30     Dr. Douglas Lowy, National Institutes of Health, Bethesda,
             HPV vaccine and the prevention of cervical cancer
    2:15     Dr. George Pasut, Chief Medical Officer of Health (A) for
             Ontario, Toronto
             HPV Vaccination in Ontario - The Path from Scientific Promise to
             Public Health Impact
    3:00     Break

    Applying Current Knowledge for Cancer Prevention

    3:15     Dr. Graham Colditz, Washington University, St Louis
             Translating research to practice: strategies and priorities for
             cancer prevention.
    4:00     Closing remarks Dr. John McLaughlin, CCO and the Samuel
             Lunenfeld Research Inst.

    Made possible through a contribution to the Gairdner Foundation by
    Merck Frosst Canada Ltd.

For further information:

For further information: Bob Ramsay, (416) 598-3970,

Organization Profile

Gairdner Foundation

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890